Cargando…
The Effect of n-3 Polyunsaturated Fatty Acids Supplementation on Serum Irisin in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
BACKGROUND: Diabetes refers to a group of metabolic diseases with blood glucose of higher than normal ranges. Furthermore, n-3 polyunsaturated fatty acids are necessary for the regulation of the activity of human function. The effect of n-3 PUFA on diabetes has been investigated in animal studies, y...
Autores principales: | Ansari, Samaneh, Djalali, Mahmoud, Mohammadzadeh Honarvar, Niyaz, Mazaherioun, Maryam, Zarei, Mahnaz, Agh, Fahimeh, Gholampour, Zahra, Javanbakht, Mohammad Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554612/ https://www.ncbi.nlm.nih.gov/pubmed/28835761 http://dx.doi.org/10.5812/ijem.40614 |
Ejemplares similares
-
Beneficial effects of n-3 polyunsaturated fatty acids on adiponectin levels and AdipoR gene expression in patients with type 2 diabetes mellitus: a randomized, placebo-controlled, double-blind clinical trial
por: Mazaherioun, Maryam, et al.
Publicado: (2016) -
Long Chain n-3 Fatty Acids Improve Depression Syndrome in Type 2 Diabetes Mellitus
por: MAZAHERIOUN, Maryam, et al.
Publicado: (2018) -
Effect of Omega-3 Polyunsaturated Fatty Acids Supplementation on Body Composition and Circulating Levels of Follistatin-Like 1 in Males With Coronary Artery Disease: A Randomized Double-Blind Clinical Trial
por: Jafari Salim, Shirin, et al.
Publicado: (2017) -
Effects of vitamin D supplementation on advanced glycation end products signaling pathway in T2DM patients: a randomized, placebo-controlled, double blind clinical trial
por: Omidian, Mahsa, et al.
Publicado: (2019) -
Evaluation of the Level of Zinc and Malondialdehyde in Basal Cell Carcinoma
por: MAJIDI, Ziba, et al.
Publicado: (2017)